The store will not work correctly in the case when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Dihydroorotate Dehydrogenase (DHODH) Catalog No.
Product Name
Application
Product Information
Citations
Vidofludimus is a novel orally active and potent DHODH inhibitor.
ML390 is a potent dihydroorotate dehydrogenase (DHODH) inhibitor. ML390 is an inducer of myeloid differentiation and causes myeloid differentiation in murine (ER-HoxA9) and human (U937 and THP1) acute myeloid leukemia (AML) models.
DSM265 is a long-duration, potent and selective dihydroorotate dehydrogenase (DHODH)) inhibitor.
BRD9185 is a Dihydroorotate dehydrogenase (DHODH) inhibitor.
BAY-2402234 is a selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of myeloid malignancies.
Dihydroorotate Dehydrogenase (DHODH) inhibitor
ASLAN003 is an orally active and potent Dihydroorotate Dehydrogenase (DHODH) inhibitor with an IC50 of 35 nM for human DHODH enzyme.
Shop By
Now Shopping by Actions Inhibitor
